Trial
NCT06866080
A Study of LCAR-AIO in Subjects With Relapsed/Refractory Autoimmune Diseases
Early Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Nanjing Legend Biotech Co.
Collaborators
—
Condition
Relapsed/Refractory Autoimmune Diseases
Intervention
LCAR-AIO T cells
Why stopped
Discontinue further development of LCAR-AIO program
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-08